Hosted on MSN1d
HC Wainwright & Co. Downgrades Inhibikase Therapeutics (IKT)
Fintel reports that on February 12, 2025, HC Wainwright & Co. downgraded their outlook for Inhibikase Therapeutics ...
Inhibikase Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
H.C. Wainwright downgraded Inhibikase Therapeutics (IKT) to Neutral from Buy without a price target after risvodetinib development was paused ...